IJCS | Volume 32, Nº1, January/ February 2019

68 Task Force. Increases in antihypertensive prescriptions and reductions in cardiovascular events in Canada. Hypertension. 2009;53(2):128-34. 6. McAlister FA, Wilkins K, Joffres M, Leenen FH, Fodor G, Gee M et al. Changes in the rates of awareness, treatment and control of hypertension in Canada over the past two decades. CMAJ. 2011;183(9):1007-13. 7. Taler SJ. Individualizing antihypertensive combination therapies: clinical and hemodynamic considerations. Curr Hypertens Rep. 2014;16(7):451. 8. Viera AJ, Furberg CD. Plasma renin testing to guide antihypertensive therapy. Curr Hypertens Rep. 2015;17(1):506. 9. Raman VK, Tsioufis C, Doumas M, Papademetriou V. Renal denervation therapy for drug-resistant hypertension: does it still work? Curr Treat Options Cardiovasc Med. 2017;19(5):39. 10. Ferrario CM, Flack JM, Strobeck JE, Smits G, Peters C. Individualizing hypertension treatment with impedance cardiography: a meta-analysis of published trials. Ther Adv Cardiovasc Dis. 2010;4(1):5-16. 11. Cybulski G. Ambulatory impedance cardiography. Berlin: Springer- Verlag Berlin Heidelberg; 2011. 12. Patterson RP. Fundamentals of impedance cardiography. IEEE EngMed Biol Mag. 1989;8(1):35-8. 13. Bour J, Kellett J. Impedance cardiography: a rapid and cost-effective screening tool for cardiac disease. Eur J Intern Med. 2008;19(6):399-405. 14. Cybulski G, Strasz A, Niewiadomski W, Gasiorowska A. Impedance cardiography: recent advancements. Cardiol J. 2012;19(5):550-6. 15. Nyboer J, Bango S, Barnett A, Halsey RH. Radiocardiograms: electrical impedance changes of the heart in relation to electrocardiograms and heart sounds. In: Proceedings of The Thrity-Second Annual Meeting of the American Society for Clinical Investigation Held in Atlantic City (NJ), May 6, 1940. J Clin Invest. 1940;19(5):773-4. 16. Kubicek WG, Karnegis JN, Patterson RP, Witsoe DA, Mattson RH. Development and evaluation of an impedance cardiac output system. Aerosp Med. 1966;37(12):1208-12. 17. Bernstein DP. A new stroke volume equation for thoracic electrical bioimpedance: theory and rationale. Crit Care Med. 1986;14(10):904-9. 18. LintonDM, GilonD. Advances in noninvasive cardiac output monitoring. Ann Card Anaesth. 2002;5(2):141-8. 19. Charloux A, Lonsdorfer-Wolf E, Richard R, Lampert E, Oswald- Mammosser M, Mettauer B, et al. A new impedance cardiograph device for the non-invasive evaluation of cardiac output at rest and during exercise: comparison with the "direct" Fick method. Eur J Appl Physiol. 2000;82(4):313-20. 20. Northridge DB, Findlay IN, Wilson J, Henderson E, Dargie HJ. Non- invasive determination of cardiac output by Doppler echocardiography and electrical bioimpedance. Br Heart J. 1990;63(2):93-7. Erratum in: Br Heart J 1990;64(5):347-8. 21. Albert NM, Hail MD, Li J, Young JB. Equivalence of the bioimpedance and thermodilutionmethods inmeasuring cardiac output in hospitalized patients with advanced, decompensated chronic heart failure. Am J Crit Care. 2004;13(6):469-79. 22. Drazner MH, Thompson B, Rosenberg PB, Kaiser PA, Boehrer JD, Baldwin BJ, et al. Comparison of impedance cardiography with invasive hemodynamic measurements in patients with heart failure secondary to ischemic or nonischemic cardiomyopathy. Am J Cardiol. 2002;89(8):993-5. 23. SagemanWS, Riffenburgh RH, Spiess BD. Equivalence of bioimpedance and thermodilution in measuring cardiac index after cardiac surgery. J Cardiothorac Vasc Anesth. 2002;16(1):8-14. 24. YungGL,FedulloPF,KinningerK,JohnsonW,ChannickRN.Comparison of impedance cardiography to direct Fick and thermodilution cardiac output determination in pulmonary arterial hypertension. Congest Heart Fail. 2004;10(2 Suppl 2):7-10. 25. Van De Water JM, Miller TW, Vogel RL, Mount BE, Dalton ML. Impedance cardiography: the next vital sign technology? Chest. 2003;123(6):2028-33. 26. Ventura HO, Taler SJ, Strobeck JE. Hypertension as a hemodynamic disease: the role of impedance cardiography in diagnostic, prognostic, and therapeutic decision making. Am J Hypertens. 2005;18(2 Pt 2):26S-43S. 27. Thompson B, Drazner MH, Dries DL, Yancy CW. Systolic time ratio by impedance cardiography to distinguish preserved vs impaired left ventricular systolic function in heart failure. Congest Heart Fail. 2008;14(5):261-5. 28. Lababidi Z, Ehmke DA, Durnin RE, Leaverton PE, Lauer RM. The first derivative thoracic impedance cardiogram. Circulation. 1970;41(4):651-8. 29. Tahvanainen A, Koskela J, Leskinen M, Ilveskoski E, Nordhausen K, Kähönen M, et al. Reduced systemic vascular resistance in healthy volunteers with presyncopal symptoms during a nitrate-stimulated tilt-table test. Br J Clin Pharmacol. 2011;71(1):41-51. 30. DeMarzo AP. Using impedance cardiography with postural change to stratify patients with hypertension. Ther Adv Cardiovasc Dis. 2011;5(3):139-48. 31. Limper U, Gauger P, Beck LE. Upright cardiac output measurements in the transition to weightlessness during parabolic flights. Aviat Space Environ Med. 2011;82(4):448-54. 32. Gielerak G, Piotrowicz E, Krzesinski P, Kowal J, Grzeda M, Piotrowicz R. The effects of cardiac rehabilitation on haemodynamic parameters measured by impedance cardiography in patients with heart failure. Kardiol Pol. 2011;69(4):309-17. 33. Khan FZ, Virdee MS, Hutchinson J, Smith B, Pugh PJ, Read PA, et al. Cardiac resynchronization therapy optimization using noninvasive cardiac output measurement. Pacing Clin Electrophysiol. 2011;34(11):1527-36. 34. Balachandran JS, Bakker JP, Rahangdale S, Yim-Yeh S, Mietus JE, Goldberger AL, et al. Effect of mild, asymptomatic obstructive sleep apnea on daytime heart rate variability and impedance cardiography measurements. Am J Cardiol. 2012;109(1):140-5. 35. de Zambotti M, Covassin N, De Min Tona G, Sarlo M, Stegagno L. Sleep onset and cardiovascular activity in primary insomnia. J Sleep Res. 2011;20(2):318-25. 36. Moertl MG, Schlembach D, Papousek I, Hinghofer-Szalkay H, Weiss EM, Lang U, et al. Hemodynamic evaluation in pregnancy: limitations of impedance cardiography. Physiol Meas. 2012;33(6):1015-26. 37. San-Frutos L, Engels V, Zapardiel I, Perez-Medina T, Almagro-Martinez J, Fernandez R, et al. Hemodynamic changes during pregnancy and postpartum: a prospective study using thoracic electrical bioimpedance. J Matern Fetal Neonatal Med. 2011;24(11):1333-40. 38. Tomsin K, Mesens T, Molenberghs G, Gyselaers W. Venous pulse transit time in normal pregnancy and preeclampsia. Reprod Sci. 2012;19(4):431-6. 39. Tang WH. Impedance monitoring in heart failure: are we really measuring hemodynamics? Am Heart J. 2009;158(2):152-3. 40. Sanford T, Treister N, Peters C. Use of noninvasive hemodynamics in hypertension management. Am J Hypertens. 2005;18(2 Pt 2):87S-91S. 41. Stason WB. Hypertension: a policy perspective, 1976-2008. J Am Soc Hypertens. 2009;3(2):113-8. 42. FerrarioCM, Basile J, BestermannW, FrohlichE, HoustonM, LacklandDT, et al. The role of noninvasive hemodynamic monitoring in the evaluation and treatment of hypertension. Ther Adv Cardiovasc Dis. 2007;1(2):113-8. 43. Flack JM. Noninvasive hemodynamic measurements: an important advance in individualizing drug therapies for hypertensive patients. Hypertension. 2006;47(4):646-7. 44. Smith RD, Levy P, Ferrario CM; Consideration of Noninvasive Hemodynamic Monitoring to Target Reduction of Blood Pressure Levels Study Group. Value of noninvasive hemodynamics to achieve blood pressure control in hypertensive subjects. Hypertension. 2006;47(4):771-7. 45. Taler SJ, Textor SC, Augustine JE. Resistant hypertension: comparing hemodynamic management to specialist care. Hypertension. 2002;39(5):982-8. Leão and Silva Impedance cardiography and hypertension Int J Cardiovasc Sci. 2019;32(1)61-69 Review Article